scispace - formally typeset
S

Serge Gauthier

Researcher at McGill University

Publications -  715
Citations -  61038

Serge Gauthier is an academic researcher from McGill University. The author has contributed to research in topics: Dementia & Disease. The author has an hindex of 93, co-authored 637 publications receiving 52775 citations. Previous affiliations of Serge Gauthier include Hamamatsu University School of Medicine & La Salle University.

Papers
More filters
Journal ArticleDOI

Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat

TL;DR: It is found that the concentration of the 5-HT metabolite 5-hy-droxyindoleacetic acid (5-HI A A) is low in the lumbar cerebrospinal fluid (CSF) of folate-deficient patients who have folATE-responsive neuropsychiatrie symptoms, and low brain 5- HT levels in the brains of rats fed folate -deficient or over-supplemented diets.
Journal ArticleDOI

Spatial disorientation in persons with early senile dementia of the Alzheimer type.

TL;DR: Occupational therapy should include the assessment of spatial orientation skills in persons who are in the early stages of dementia, because spatial disorientation poses a danger and limits a person's ability to independently perform daily activities that require navigation outside of the home.
Journal ArticleDOI

The benefits of group occupational therapy for patients with Parkinson's disease.

TL;DR: The results showed that the subjects of the treated experimental group maintained their functional status after 1 year, demonstrated a significant decrease of bradykinesia, and perceived a significant improvement in their psychological well-being.
Journal ArticleDOI

Alzhemed: a potential treatment for Alzheimer's disease.

TL;DR: Alzhemed appears to be well tolerated with long-term exposure and reduces CSF Abeta(42) levels in mild-to-moderate AD subjects, and these findings will be discussed in the context of two large-scale randomized, double-blind, placebo-controlled Phase III clinical trials that are currently being conducted to test the long- term safety and efficacy of Alzhemed.